港股异动 | 启明医疗-B(02500)涨超7% Cardiovalve三尖瓣置换系统中期临床显示安全及疗效良好

智通财经
Nov 19

智通财经APP获悉,启明医疗-B(02500)涨超7%,截至发稿,涨7.02%,报2.44港元,成交额454.41万港元。

消息面上,11月19日,启明医疗公布创新经导管三尖瓣膜置换系统Cardiovalve在TARGET研究中期临床结果。TARGET研究为前瞻性、多中心单组临床试验,涵盖德国、西班牙、意大利、加拿大及英国25个中心,共125名平均77岁患者。研究显示,器械平均手术时间为58±29分钟,术中成功率88%,植入组成功率达95%。术后6个月随访显示,100%患者无中度以上反流,心功能改善至I/II级者88%,12个月提升至90%,生活质量问卷平均提升20分,6分钟步行距离分别增加44米及32米。

安全性方面,全因死亡率6.4%(8/125),心衰再住院率1.6%,心包填塞、致残性卒中和需肾脏替代治疗的急性肾损伤事件发生率均较低启明医疗表示,本次在PCRL ondon Valves2025年大会上发布的Cardiovalve三尖瓣置换系统中期临床数据,充分展现了该产品在治疗严重三尖瓣反流方面的卓越临床效果,获得与会国际临床专家的高度认可。公司将持续积极推进包括Cardiovalve系统在内的创新产品的全球临床注册开发进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10